Neuropace Inc
NASDAQ:NPCE
Wall Street
Price Targets
NPCE Price Targets Summary
Neuropace Inc
According to Wall Street analysts, the average 1-year price target for
NPCE
is 18.19 USD
with a low forecast of 13.13 USD and a high forecast of 21 USD.
NPCE Last Price Targets
Neuropace Inc
The latest public price target was made on Mar 14, 2024 by
Larry Biegelsen
from
Wells Fargo
,
who expects
NPCE
stock to
rise by 47%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Larry Biegelsen
Wells Fargo
|
20
USD
Upside 47% |
1 month ago
Mar 14, 2024
|
Wells Fargo Upgrades NeuroPace Inc (NPCE) to Overweight
StreetInsider
|
|
Ross Osborn
Cantor Fitzgerald
|
11
USD
Downside 19% |
5 months ago
Nov 10, 2023
|
Epilepsy-Focused MedTech NeuroPace Has Attractive Entry Point, Competitive Position
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NPCE's stock price target?
Price Target
18.19
USD
According to Wall Street analysts, the average 1-year price target for
NPCE
is 18.19 USD
with a low forecast of 13.13 USD and a high forecast of 21 USD.
What is Neuropace Inc's Revenue forecast?
Projected CAGR
19%
For the last 3 years the
compound annual growth rate for
Neuropace Inc's revenue is
17%.
The projected
CAGR
for the next 3 years is
19%.
You don't have any saved screeners yet
